Viewing Study NCT01756261


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-04-17 @ 12:41 PM
Study NCT ID: NCT01756261
Status: COMPLETED
Last Update Posted: 2018-06-19
First Post: 2012-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module